# Core Laboratories Inc.: filings

CLB · NYSE · CIK 1958086 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/clb.md) · [Financials](/companies/clb/financials.md) · [Filings](/companies/clb/filings.md) · [Insiders](/companies/clb/insiders.md)

## Reports and events: 41 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 72, 8-K 23, SCHEDULE 13G/A 15, 10-Q 10, S-8 POS 10, 4/A 5, 11-K 4, ARS 4, DEFA14A 4, SD 4, 10-K 3, 3 3, CORRESP 3, DEF 14A 3, SC 13G 3, SC 13G/A 3, 8-K/A 2, S-4/A 2, 424B3 1, 425 1, 8-K12B 1, EFFECT 1, NT 10-K 1, S-4 1, S-8 1, SCHEDULE 13G 1, UPLOAD 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-25 | 20:51 ET | [8-K](/filings/0001193125-26-365271.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-365271 |
| 2026-07-30 | 21:13 ET | [10-Q](/filings/0001193125-26-326345.md) | Quarterly report, period 2026-06-30 | 0001193125-26-326345 |
| 2026-07-29 | 20:43 ET | [8-K](/filings/0001193125-26-324101.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-324101 |
| 2026-05-13 | 20:54 ET | [8-K](/filings/0001193125-26-221857.md) | 5.07 Shareholder vote results | 0001193125-26-221857 |
| 2026-05-01 | 22:03 ET | [10-Q](/filings/0001193125-26-198109.md) | Quarterly report, period 2026-03-31 | 0001193125-26-198109 |
| 2026-04-29 | 20:43 ET | [8-K](/filings/0001193125-26-192018.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-192018 |
| 2026-03-31 | 21:21 ET | [DEF 14A](/filings/0001193125-26-134986.md) | Proxy statement, period 2026-03-31 | 0001193125-26-134986 |
| 2026-03-23 | 20:59 ET | [8-K](/filings/0001193125-26-119934.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-119934 |
| 2026-03-23 | 01:54 ET | [10-K](/filings/0001193125-26-118177.md) | Annual report, period 2025-12-31 | 0001193125-26-118177 |
| 2026-03-17 | 10:15 ET | [8-K/A](/filings/0001193125-26-109251.md) | 2.02 Results of operations | 0001193125-26-109251 |
| 2026-03-05 | 21:11 ET | [8-K](/filings/0001193125-26-093962.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-093962 |
| 2026-02-04 | 21:58 ET | [8-K](/filings/0001193125-26-037789.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-037789 |
| 2025-10-23 | 20:05 ET | [10-Q](/filings/0001193125-25-248736.md) | Quarterly report, period 2025-09-30 | 0001193125-25-248736 |
| 2025-10-22 | 20:15 ET | [8-K](/filings/0001193125-25-246793.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-246793 |
| 2025-07-25 | 22:25 ET | [10-Q](/filings/0000950170-25-098473.md) | Quarterly report, period 2025-06-30 | 0000950170-25-098473 |
| 2025-07-23 | 20:20 ET | [8-K](/filings/0000950170-25-097897.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-097897 |
| 2025-05-27 | 20:27 ET | [8-K](/filings/0000950170-25-077738.md) | 5.07 Shareholder vote results | 0000950170-25-077738 |
| 2025-04-28 | 22:36 ET | [10-Q](/filings/0000950170-25-058900.md) | Quarterly report, period 2025-03-31 | 0000950170-25-058900 |
| 2025-04-23 | 20:41 ET | [8-K](/filings/0000950170-25-057483.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-057483 |
| 2025-03-31 | 20:58 ET | [DEF 14A](/filings/0000950170-25-047865.md) | Proxy statement, period 2025-03-31 | 0000950170-25-047865 |
| 2025-02-13 | 23:18 ET | [10-K](/filings/0000950170-25-019072.md) | Annual report, period 2024-12-31 | 0000950170-25-019072 |
| 2025-01-29 | 21:45 ET | [8-K](/filings/0000950170-25-010552.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-010552 |
| 2024-10-24 | 21:30 ET | [10-Q](/filings/0000950170-24-117122.md) | Quarterly report, period 2024-09-30 | 0000950170-24-117122 |
| 2024-10-23 | 20:31 ET | [8-K](/filings/0000950170-24-116676.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-116676 |
| 2024-07-25 | 21:03 ET | [10-Q](/filings/0000950170-24-086610.md) | Quarterly report, period 2024-06-30 | 0000950170-24-086610 |
| 2024-07-24 | 20:37 ET | [8-K](/filings/0000950170-24-086092.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-086092 |
| 2024-05-10 | 21:01 ET | [8-K](/filings/0000950170-24-057934.md) | 5.07 Shareholder vote results | 0000950170-24-057934 |
| 2024-04-25 | 20:38 ET | [10-Q](/filings/0000950170-24-048414.md) | Quarterly report, period 2024-03-31 | 0000950170-24-048414 |
| 2024-04-24 | 20:35 ET | [8-K](/filings/0000950170-24-047646.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-047646 |
| 2024-03-25 | 20:38 ET | [8-K](/filings/0000950170-24-035962.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-035962 |
| 2024-03-19 | 22:07 ET | [DEF 14A](/filings/0000950170-24-033021.md) | Proxy statement, period 2024-03-18 | 0000950170-24-033021 |
| 2024-02-15 | 00:08 ET | [10-K](/filings/0000950170-24-015483.md) | Annual report, period 2023-12-31 | 0000950170-24-015483 |
| 2024-02-15 | 00:06 ET | [8-K/A](/filings/0000950170-24-015482.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-015482 |
| 2024-01-31 | 22:16 ET | [8-K](/filings/0000950170-24-009489.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-009489 |
| 2023-11-02 | 20:11 ET | [10-Q](/filings/0000950170-23-058206.md) | Quarterly report, period 2023-09-30 | 0000950170-23-058206 |
| 2023-11-01 | 20:51 ET | [8-K](/filings/0000950170-23-057543.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-057543 |
| 2023-07-27 | 21:05 ET | [10-Q](/filings/0000950170-23-035213.md) | Quarterly report, period 2023-06-30 | 0000950170-23-035213 |
| 2023-07-26 | 20:32 ET | [8-K](/filings/0000950170-23-034753.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-034753 |
| 2023-07-18 | 21:15 ET | [8-K](/filings/0000950170-23-033405.md) | 1.02 Termination of a material agreement | 0000950170-23-033405 |
| 2023-07-03 | 21:40 ET | [8-K](/filings/0000950170-23-031189.md) | 5.07 Shareholder vote results | 0000950170-23-031189 |
| 2023-05-05 | 01:35 ET | [8-K](/filings/0000950170-23-018053.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950170-23-018053 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.